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ABSTRACT
The interactions of archetypical nucleic acid ligands
with the HIV-1 polypurine tract (PPT) RNA:DNA
hybrid, as well as analogous DNA:DNA, RNA:RNA
and swapped hybrid substrates, were used to probe
structural features of the PPT that contribute to its
specific recognition and processing by reverse
transcriptase (RT). Results from intercalative and
groove-binding ligands indicate that the wild-type
PPT hybrid does not contain any strikingly unique
groove geometries and/or stacking arrangements
that might contribute to the specificity of its
interaction with RT. In contrast, neomycin bound
preferentially and selectively to the PPT near the
5’(rA)4:(dT)4 tract and the 3’ PPT-U3 junction.
Nuclear magnetic resonance data from a complex
between HIV-1 RT and the PPT indicate RT contacts
within the same regions highlighted on the PPT by
neomycin. These observations, together with the
fact that the sites are correctly spaced to allow
interaction with residues in the ribonuclease H
(RNase H) active site and thumb subdomain of the
p66 RT subunit, suggest that despite the long cleft
employed by RT to make contact with nucleic acids
substrates, these sites provide discrete binding
units working in concert to determine not only
specific PPT recognition, but also its orientation
on the hybrid structure.
INTRODUCTION
Converting single-stranded viral RNA into double-
stranded DNA for integration is an essential step in
HIV-1 replication mediated by reverse transcriptase (RT),
a multifunctional enzyme performing both DNA polymer-
ase and ribonuclease H (RNase H) activities (1,2). Initial
polymerization of minus-strand DNA is primed by host-
derived tRNA, whereas subsequent plus-strand synthesis
requires viral primers deﬁned as the 30 and central poly-
purine tracts (PPTs) (3). These identical stretches of
genomic RNA are not aﬀected by template degradation
associated with minus-strand synthesis. Instead, they are
created by precise 30-cleavage and eventually removed after
plus-strand extension has been successfully initiated (1–3).
CatalyzedbytheRNaseHfunctionofRT,these hydrolytic
events must be completed with high precision and spec-
iﬁcity to produce proviral DNA of well-deﬁned ends.
The fact that imprecise PPT processing leads to impaired
integration provides a powerful motivation for investigat-
ing the structural determinants of RNase H activity as
potential targets for new antiviral strategies (4–6).
In vitro studies have demonstrated that single-base
substitutions induce only minor variations in the PPT
cleavage pattern, suggesting that its structure is recognized
as a whole by RT (7–10). High-resolution structural
analysis has been reported for RNA:DNA duplexes
covering diﬀerent sections of the PPT sequence and
contiguous regions (Figure 1), revealing signiﬁcant devia-
tions from typical hybrid structures with intermediate
characteristics between canonical A- and B-type double
helices (11–14). In particular, an octamer spanning the
junction between PPT and the adjacent unique 30 (U3)
sequence has shown a wide major groove approaching
B-type dimensions and a bend of  138 centered around
the PPT-U3 cleavage junction (15). Constructs comprising
the rA:dT tracts located 50 of the cleavage site exhibited
a signiﬁcantly narrower minor groove than in typical
hybrids (16). Minor groove compression was also
observed in the crystal structure of a complex between
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upstream (17), which also displayed an unusual pattern
of weakly paired, unpaired and mispaired bases (Figure 1).
Chemical probing experiments performed in the absence
of protein demonstrated that these pairing anomalies
constitute an intrinsic characteristic of the PPT and not
the direct result of RT binding (18). The hypothesis that
these unique structural features may serve as speciﬁc
recognition sites prompted further studies to determine
the eﬀects of base-pairing and substrate geometry on PPT
cleavage speciﬁcity, which enabled mapping of motifs
necessary for proper positioning of the RNase H catalytic
site onto the PPT-U3 junction (Figure 1) (19–23).
In this report, the interactions between non-covalent
probes selected from diﬀerent classes of nucleic acid
binders and a series of PPT substrates were assessed using
direct infusion electrospray ionization (ESI) (24,25) and
Fourier transform ion cyclotron resonance (FTICR)
(26,27) mass spectrometry. Taking advantage of the
inherently low energy aﬀorded by this ionization techni-
que to assess the stoichiometry and binding aﬃnity
provided by small molecule ligands (28–30), we recently
probed the speciﬁc interactions between the nucleocapsid
(NC) domain of Gag and isolated RNA stemloops of the
HIV-1 packaging signal (31,32). We have now implemen-
ted this approach to evaluate the ability of archetypical
ligands to form stable complexes with PPT, determine
their binding modes and identify their speciﬁc sites on
the duplex structure. Selected interactions were further
investigated using high-resolution nuclear magnetic reso-
nance (NMR) spectroscopy to conﬁrm the stoichiometry
and position of putative binding sites. Isothermal titration
calorimetry (ITC) was ﬁnally employed to assess the
stability of diﬀerent PPT complexes and obtain the
thermodynamic characteristics of their binding equilibria.
The observed interactions are discussed in the context of
structural features of the PPT that may guide selective RT
processing to create the plus-stand primer from within the
viral RNA genome.
MATERIALS AND METHODS
PPT substrates
All ribo- and deoxyribonucleotide phosphoramidites were
purchased from Glen Research Corporation (Sterling,
VA, USA). Oligonucleotides (20-mers) of DNA and RNA
were synthesized using standard phosphoramidite chem-
istry on a PE Biosystems Expedite 8909 nucleic acid
synthesizer. The individual strands were puriﬁed using
preparative polyacrylamide gel electrophoresis (PAGE),
dialyzed against sterile ddH2O, then against either ESI
(100mM ammonium acetate, pH 7.0) or NMR buﬀer
(80mM NaCl, 10mM phosphate, pH 7.0), and ﬁnally
quantiﬁed with a UV–Vis spectrophotometer (260nm).
The single strands were ﬁnally annealed by mixing
equimolar amounts of the desired constructs, heating the
solution to 908C for 3min, and allowing the samples to
slow-cool to form the duplex.
Mass spectrometry
All analyses were performed on a Bruker Daltonics
(Billerica, MA, USA) Apex III FTICR mass spectrometer
equipped with a 7T actively shielded superconducting
magnet and a nano-ESI source built in-house. Desolvation
temperature, skimmer voltage and other source parameters
were optimized to allow for the observation of intact
RNA non-covalent complexes, as previously described
(31–34). Analyte solutions were mixed with iso-propanol
immediatelybeforeanalysistoaﬁnalconcentrationof10%
involumetoassistdesolvation.Typically,5mlsampleswere
loaded into the nano-ESI needle and a spray voltage of
<1kV was applied to the solution through a stainless steel
wire inserted in the needle’s back end. No solvent pumps
were necessary, as the solution ﬂow-rate was dictated by
the applied voltage and the size of the nano-ESI needle
tip (typically  1–2mm). Spectra were acquired in nega-
tive ionization mode and processed using XMASS 7.0.2
(Bruker Daltonics, Billerica, MA, USA). Scans were
completed in broadband mode that allowed for a typical
Figure 1. PPT-containing RNA:DNA hybrid. Indicated are regions for which high-resolution structures are available and their relationship with the
sequence employed in this study.
2800 Nucleic Acids Research, 2008, Vol. 36, No. 8150000 resolving power at m/z 2000. The spectra were
externallycalibratedusinga1mg/ml solutionofCsI,which
produced a series of peaks throughout the mass range
of 1000–6000m/z and enabled to achieve a typical mass
accuracy of 20p.p.m. or better across the range. Each
analysis was performed a minimum of three times and only
representative spectra were shown.
In tandem MS experiments, the precursor ion of interest
was isolated in the FTICR cell using correlated RF sweeps
(CHEF) (35) and then activated through sustained
oﬀ-resonance irradiation–collision-induced dissociation
(SORI–CID) (36). Frequency oﬀsets below and above
the resonant frequency of the precursor ion were sampled
to avoid possible ‘blind spots’ in the product spectra. Best
results were achieved by using irradiation frequencies that
were 600–2000Hz below that of the precursor ion. Typical
activation regimes were reached by applying oﬀ-resonant
pulses for 250ms, using 26–31dB attenuation of the
maximum power output allowed by the hardware. Argon
was used as the collision gas in pulsed bursts of
100–250ms, which resulted in momentary increases from
1 10
 11 to 1 10
 7 mbar of the background pressure
measured by the instrument gauge located underneath the
ion optics. No attempt was made to determine the actual
pressure within the FTICR cell.
NMR analysis
HIV-1 wild-type single-stranded RNA and DNA oligo-
nucleotides were prepared and annealed as described
above. The duplex was dialyzed against 80mM NaCl and
10mM NaH2PO4/Na2HPO4 at pH 7.0. Final duplex
concentration was 225mM (61.9nmol). Neomycin B was
titrated in 0.25 equivalents (15.5nmol) up to a total of 2.0
equivalents (123.8nmol). After each addition, the complex
was equilibrated for 20min before the
1H NMR was
acquired. RNase H-deﬁcient mutant RT (E478Q RT) was
prepared as described (37). The E478Q RT:PPTwt com-
plex was formed before ﬁnal dialysis by mixing 11 nmol of
each. The complex was then dialyzed into phosphate
buﬀer using an Amicon Ultra-4 (MWCO 3000) centricon
(Millipore, Billerica, MA). Final glycerol concentration
was  8%, and ﬁnal complex concentration was  40mM.
One-dimensional
1H NMR data were acquired using a
Bruker Biospin DMX600, equipped with a triple reso-
nance, triple axis pulsed ﬁeld-shielded gradient TXI HCN
cryoprobe. Titrations of PPT substrate with neomycin B
and RT were carried out at 108C and 308C, respectively,
based on optimal temperatures found for observing the
spectra of each complex. All 1D spectra were processed
with (TopSpin software, Bruker Biospin, Billerica,
MA, USA).
Isothermal titration calorimetry
HIV-1 wild-type PPT duplex was dialyzed in 80mM or
240mM NaCl and 10mM NaH2PO4/Na2HPO4 at pH 7.0.
Separate solutions of neomycin B were prepared using the
same buﬀers. ITC experiments were performed at 308Co n
a MicroCal VP-ITC (MicroCal, Inc., Northhampton,
MA, USA). In a typical experiment, 5ml aliquots of
800mM neomycin B were injected from a 275ml rotating
syringe (313 r.p.m.) into an isothermal chamber contain-
ing 1.42ml of 20mM HIV wild-type PPT duplex. The
initial delay before the ﬁrst injection was 180s. The
duration of each 5ml injection was 10s with 240s delay
between each injection. The corresponding control experi-
ment was also run in which neomycin B was injected into
each buﬀer alone to take into account the heats of
dilution. Each injection generated a heat burst curve
(microcalories per second versus seconds) that was
integrated using (Origin 5.0 software, Silverdale
Scientiﬁc, Buckinghamshire, UK) to obtain the heat
associated with each injection. After the heats of dilution
were subtracted, the results were plotted (kilocalories/
mole of injection versus molar ratio). The plot was ﬁt with
a model of either one set or two sets of equivalent sites
using the Origin 5.0 software.
RESULTS AND DISCUSSION
Nucleic acid ligands with well-characterized binding
modes can serve as non-covalent probes for assaying the
ability of target substrates to sustain speciﬁc interactions
and for identifying the structural features necessary for
stable binding (31,32). For this purpose, ligands employed
here were selected among general intercalators (ethidium
bromide), minor groove binders (distamycin A), mixed-
mode intercalator/minor groove binders (mitoxantrone)
and multifunctional polycationic aminoglycosides (neo-
mycin B) (Scheme 1) (38–40). The extensive knowledge of
the chemical properties of these ligands, as well as their
binding preferences, allows for valid conclusions on the
speciﬁc nature of target substrates. The eﬀects of helical
structure and pairing anomalies on binding mode were
investigated by employing not only a consensus PPT
RNA:DNA hybrid (PPTwt, Scheme 2), but also constructs
in which both strands consisted exclusively of ribo- or
deoxyribonucleotides (PPTRNA and PPTDNA, respec-
tively). A control hybrid duplex designated PPTswp was
also included in which the DNA and RNA sequences were
interchanged (Scheme 2).
PPT-ligandbinding modes
The formation of non-covalent complexes between selected
binders and PPT constructs was monitored directly by
high-resolution mass spectrometry to provide unambig-
uous information about the composition and stoichiome-
try of any species at equilibrium in solution. Reversing
established multiplexed strategies in which groups of
ligands are presented together to a single target in solution
(31,41,42), we treated equimolar mixtures of the four PPT
constructs with each individual probe to directly compare
binding speciﬁcity. This approach promotes competition
among substrates and yields distinctive assembly distribu-
tions that reﬂect the strength of the respective interactions.
Due to the similar charging properties of the various
species in the mixture, signal intensities correlate well
with relative abundances in solution, which can be readily
translated into relative scales of binding aﬃnities (see
Materials and methods section).
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by the titration of a solution containing 5mM of each PPT
substrate with the mixed-mode binder mitoxantrone
(Figure 2). ESI-FTICR analysis of the initial mixture
provided fully resolved signals for all four substrates,
together with typical cation adducts observed in nucleic
acid analysis (Figure 2a). Non-covalent assemblies con-
taining up to three ligand units were readily detected for
each duplex after addition of one equivalent of mitoxan-
trone per substrate (Figure 2b, see Materials and methods
section). In a clear concentration-dependent fashion,
larger amounts of ligand induced the binding of additional
units and increased the ratio between bound and free
substrates in solution. When a 10-fold excess was added,
the PPTDNA construct bound ﬁve mitoxantrone equiva-
lents, whereas the other substrates provided a maximum
binding of only four units (Figure 2c). While the available
sites were progressively occupied during the titration,
binding of one ligand did not appear to facilitate
or hamper that of the next, suggesting that the
sites are independent and cooperative eﬀects are
insigniﬁcant. The patterns of assembly formation and
substrate consumption are consistent with the following
relative scale of binding aﬃnities: PPTDNA>PPTwt 
PPTRNA PPTswp.
Analyzed in identical fashion, each class of binders
formed stable complexes with distinctive binding modes.
As summarized in Table 1, ethidium bromide displayed
a scale of relative binding aﬃnities matching that of
mitoxantrone, as expected from their similar intercalating
activities. Both molecules provided signiﬁcantly higher
stoichiometries than the remaining non-covalent probes
in the study, consistent with their ability to insert into
multiple positions of the double-stranded PPT structure.
The preference manifested by these binders for PPTDNA
can be ascribed to the tighter nature of base stacking in
canonical B-type helices than in either canonical A-type or
hybrid structures, which accounts for greater stabilization
of intercalating interactions. The maximum stoichiometry
obtained from these molecules (Figure 3a) matches the
presence of ﬁve possible sites between adjacent GC pairs,
which are particularly favorable to intercalation (43,44).
The fact that only four units bound to the other PPT
constructs is consistent with more limited stabilization
aﬀorded by the less-extensive stacking of A-type and
hybrid double helices.
The minor groove binder distamycin A also manifested
an overall preference for PPTDNA, but displayed lower
overall stoichiometries (Table 1). In this case, the relative
scale of binding aﬃnities reﬂects the increasing size of the
minor groove in the PPT series, with hybrid structures
exhibiting intermediate properties between the more
favorable narrow groove of the B-type DNA duplex and
the wider A-type RNA (12,15). This class of oligopeptide
molecules binds preferentially to sites that include four or
ﬁve consecutive AT base pairs, establishing H-bonds with
the N3-adenine and O2-thymine (45). For this reason,
the two (dA)4:(dT)4 tracts in the 50 region of the DNA
duplex are likely responsible for the tight binding of the
ﬁrst two units (Figure 3b). The third molecule required
to account for the observed stoichiometry could enjoy
C1 A2 A3 A4 A5 G6 A7 A8 A9 A10G11G12G13G14G15G16 A17C18T19G20
G20T19T18T17T16C15T14T13T12T11C10C9 C8 C7 C6 C5 T4 G3 A2 C1
PPTDNA
Obs. 12228.33 Da
Calc. 12228.10 Da
−16−15 −14 −13 −12−11 −10 −9 −8 −7 −6 −5 −4 −3 −2 −1+ 1+ 2 + 3+ 4
G20T19T18T17T16C15T14T13T12T11C10C9 C8 C7 C6 C5 T4 G3 A2 C1
c1 a2 a3 a4 a5 g6 a7 a8 a9 a10 g11g12g13g14g15g16a17 c18u19g20
Obs. 12534.34 Da
Calc. 12533.95 Da PPTWT
g20 u19u18u17u16c15u14u13u12 u11c10c9 c8 c7 c6 c5 u4 g3 a2 c1
c1 a2 a3 a4 a5 g6 a7 a8 a9 a10 g11g12g13g14g15g16a17 c18u19g20
PPTRNA
Obs. 12727.88 Da
Calc. 12727.74 Da
g20 u19u18u17u16c15u14u13u12 u11 c10 c9 c8 c7 c6 c5 u4 g3 a2 c1
C1 A2 A3 A4 A5 G6 A7 A8 A9 A10G11G12G13G14G15G16 A17C18T19G20
PPTswp
Obs. 12421.79 Da
Calc. 12421.86 Da
Scheme 2. PPT-containing duplexes. PPTwt: wild-type hybrid from
HIV-1 subtype A; PPTRNA: both strands made of RNA; PPTDNA: both
strands DNA; PPTswp: sequences of the RNA and DNA strands
swapped. Sequences are numbered from 50 to 30, and biological
numbering relative to the scissile  1g/+1a phosphodiester bond is
indicated. Nucleotides in uppercase denote DNA, and lowercase
denotes RNA. The monoisotopic mass observed by nanospray-
FTICR for each duplex construct is reported together with the
respective mass calculated from sequence (see Materials and methods
section).
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Scheme 1. Archetypical nucleic acid ligands used as non-covalent
probes in this study: (a) ethidium bromide, representative of base
intercalators; (b) distamycin A, a typical minor-groove binder;
(c) mitoxantrone, a mixed-mode intercalator/groove binder; and
(d) neomycin B, a polycationic aminoglycoside.
2802 Nucleic Acids Research, 2008, Vol. 36, No. 8only weaker stabilization from speciﬁc interactions
with the non-consecutive AT pairs at the 30-end of the
construct (Scheme 2). Considering the overall unfavorable
situation aﬀorded by the minor groove of double-stranded
RNA, it was not surprising that PPTRNA bound only one
equivalent within the range of concentrations covered by
the titration experiments (Figure 3b).
Unique among the probes used in the study, the
aminoglycoside neomycin B exhibited its highest relative
aﬃnity for the wild-type RNA:DNA PPT, while PPTDNA
fell to the bottom of the scale (Figure 3c and Table 1). This
class of molecules has a pronounced ability to interact
with motifs that disrupt regular double-helical pattern,
including non-canonical pairs, platforms, bulges, bends
and other anomalies (46). These peculiar features can
provide unique H-bonding opportunities for the amino
groups of aminoglycosides, which are placed in optimal
positions by the ﬂexible 2-deoxystreptamine scaﬀold (46).
In addition, electrostatic interactions between protonated
amino groups on the aminoglycoside molecule and highly
electronegative areas on the motif surface contribute to
further stabilize binding of this class of ligands (31,32,46).
The fact that PPTwt displayed the highest aﬃnity in the
substrate series suggests that unusual structural character-
istics set it apart from the canonic helical structures of
PPTRNA and PPTDNA. These favorable features require
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Figure 2. Nanospray-FTICR mass spectra of: (a) the initial equimolar mixture of the four PPT substrates (5mM each); (b) the products obtained
after a 1-fold per substrate addition of the mixed-mode binder mitoxantrone; (c) the assemblies after 10-fold ligand addition (see Materials and
methods section). Red ﬁlled square: PPTDNA; orange ﬁlled diamond: PPTRNA; green ﬁlled triangle: PPTwt; blue ﬁlled inverted triangle: PPTsw and
black ﬁlled circle: bound ligand. The high resolution and accuracy aﬀorded by this analytical platform enabled unambiguous identiﬁcation of the
diﬀerent species in solution according to their unique molecular masses (see also Scheme 2).
Table 1. Summary of the stoichiometries and relative binding aﬃnities obtained by titrating an equimolar mixture of the four PPT substrates with
increasing amounts of each individual ligand (see Materials and methods section)
Ligand PPTwt PPTswp PPTDNA PPTRNA Relative aﬃnity
Ethidium bromide (units bound) 4 4 5 4 DNA>WT RNA Swp
Mitoxantrone (units bound) 4 4 5 4 DNA>WT RNA Swp
Distamycin A (units bound) 2 2 3 1 DNA>WT>Swp>RNA
Neomycin B (units bound) 2 1 1 1 WT>RNA>Swp>DNA
The reported stoichiometry corresponds to the maximum number of units observed upon 10-fold addition of ligand over the total amount of each
duplex substrate in solution.
Nucleic Acids Research, 2008, Vol. 36, No. 8 2803that the PPT be coded in the RNA strand of the hybrid
duplex, as indicated by the signiﬁcantly lower aﬃnity of
the sequence-swapped construct PPTswp, in which the PPT
is present in the DNA strand (Figure 3c). The fact that
neomycin B provided the lowest stoichiometry and highest
aﬃnity in the ligand series while competing for the PPTwt
substrate further indicates the unique character of the
structures involved in these speciﬁc interactions.
PPT-aminoglycoside bindingsites
The presence of multiple basic groups on a ﬂexible
2-deoxystreptamine scaﬀold makes the nature of amino-
glycoside binding very similar to that of basic peptides
(Scheme 1) (46). In fact, nucleic acid motifs that are
speciﬁcally recognized by aminoglycosides also have
a strong tendency to favor stable protein interactions
(32). For this reason, mapping the speciﬁc binding sites of
neomycin B on the wild-type RNA:DNA hybrid could
provide important information on the RT-PPT recogni-
tion mechanism. This was addressed by combining
tandem mass spectrometry (MS/MS) and NMR spectro-
scopy. The former approach involves isolating the
precursor ion of interest within the FTICR cell, submit-
ting it to low-energy collisions with target gas, and analyz-
ing the fragments produced by the dissociation process,
which are characteristic of the precursor composition and
chemical structure (47,48). We recently reported that the
fragmentation patterns obtained from intact ligand–RNA
complexes contain series of sequence ions with distinctive
gaps corresponding to the nucleotides involved in ligand
interactions (32). This gas-phase footprinting technique
successfully localized the aminoglycoside sites on diﬀerent
stem-loop domains of the HIV-1 packaging signal, corre-
lating their location with the position of known contacts
between these structures and the viral nucleocapsid
protein.
When applied to the PPTwt RNA:DNA hybrid binding
a single neomycin B, MS/MS provided ion series
consistent with fragmentation of both strands (Figure 4).
Importantly, protection eﬀects induced by the ligand
inhibited the fragmentation of nucleotides located across
the PPT-U3 junction, identifying this biologically-critical
region as one of the speciﬁc binding sites. When the
assembly containing two units of neomycin B was
analyzed, the characteristic ion series provided two
distinctive gaps in their regular patterns, with the ﬁrst
matching the PPT-U3 junction and the second corre-
sponding to nucleotides located around the 50 (rA)4:(dT)4
tract at the opposite end of the hybrid (Figure 5). The
regions of protection are in good agreement with binding
sites of the RNase H active site and thumb subdomain of
the p66 RT subunit in the RT PPT complex (Figure 1).
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Figure 3. Nanospray-FTICR mass spectra of the initial equimolar mixture of the four PPT substrates (5mM each) after a 10-fold per substrate
addition of: (a) ethidium bromide; (b) distamycin A; (c) neomycin B (see Materials and methods section). Red ﬁlled square: PPTDNA; orange ﬁlled
diamond: PPTRNA; green ﬁlled triangle: PPTwt; blue ﬁlled inverted triangle: PPTsw; open circle: ethidium; open diamond: distamycin A; and asterisk:
neomycin B.
2804 Nucleic Acids Research, 2008, Vol. 36, No. 8It is important to note that the results provided by
the complex with one ligand did not display any sign
of protection at, or around, the 50 (rA)4:(dT)4 tract.
Therefore, the absence of alternative populations in which
either site may be individually occupied indicates that the
PPT-U3 junction possesses signiﬁcantly higher aﬃnity
than the 50 (rA)4:(dT)4 tract and that the latter is occupied
only after the former is saturated. This interpretation is
supported by electrostatic surfaces generated by Delphi
(49) from the high-resolution coordinates obtained in refs.
(15,17), which show very distinctive electronegative
patches located at the PPT-U3 junction and 50
(rA)4:(dT)4 tract, with the former providing a higher
density. It is also consistent with the recognition of the
RNase domain of RT at the PPT-U3 junction through
primarily electrostatic interactions with the phosphodies-
ter backbone of the PPT substrate.
Further insights into the position of the speciﬁc binding
sites were revealed by high-resolution
1H NMR. Ligand
binding to the wild-type PPT was followed by monitoring
changes in the imino proton spectrum of PPTwt upon
titration with neomycin B in increments of 0.25 equiva-
lents to a ﬁnal 2:1 ligand:substrate ratio (Figure 6a). The
imino proton chemical shift assignments are indicated for
the free PPTwt and were determined using 2D NOESY
spectra (50). Upon addition of neomycin B to PPTwt,
perturbations are observed for a subset of imino proton
resonances. After addition of one equivalent of ligand, a
shift in the imino proton signals was detected for g( 1),
T(+1) and G(+2) (indicated by the arrows), consistent
with selective binding at the PPT-U3 junction. In addition,
uniformly subtle downﬁeld shifts were observed for imino
protons assigned to the G-tract 50 of the PPT-U3 junction,
which further localizes binding of neomycin B to this end
of the PPT. After the primary site was saturated, addition
of a second equivalent did not introduce any detectable
shift of the imino protons, but caused only a broadening
of their signals. This behavior is typical of intermediate
chemical exchange processes on the NMR timescale and
is suggestive of a weaker, more non-speciﬁc binding
interaction(s) between ligand and PPT substrate. While
the NMR data does not allow mapping of this secondary
site(s), the observation of consecutive binding events in the
NMR titrations is consistent with the observation of high
and low aﬃnity sites in the ESI-FTICR experiments.
In order to validate the relevance of using small mole-
cule ligands as probes for understanding how HIV-1 RT
may interact with its PPT substrate, we have acquired
NMR data on a HIV-1 RT PPT complex, which could be
compared with those obtained from PPT upon aminogly-
coside binding (Figure 6b). As with neomycin, binding
of an RNase H-deﬁcient mutant RT (E478Q RT) to the
wild-type PPT was followed by monitoring changes in
the imino proton spectrum of PPTwt upon titrating one
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Figure 4. Tandem mass spectrum of the non-covalent 1:1 PPTwt:neomycin B complex (observed mass 13148.74 Da, calculated from sequence
13148.26 Da, see Materials and methods section). For clarity, only some of the characteristic ion series are labeled on the spectrum, which contain
either the 50-o r3 0-end (e.g. ax B and yx, with x indicating the numeration from the respective end;  B indicates the loss of nucleobase at the site of
cleavage). The asterisk symbol identiﬁes products containing noncovalently bound neomycin B. All product ions observed for the DNA and RNA
strands that constitute the substrate are reported on the respective sequences to highlight nucleotides prevented from undergoing fragmentation in the
presence of bound ligand (32). The lines mark the phosphodiester bond cleaved by the gas-phase dissociation processes, pointing toward the
respective end included in each fragment; asterisk indicates products containing noncovalently bound neomycin B. A clear gap in the fragmentation
pattern exhibited by the DNA and RNA strands identiﬁes the position of protected nucleotides.
Nucleic Acids Research, 2008, Vol. 36, No. 8 2805equivalent of RT (Figure 6b). In previous studies, this
RNase H-deﬁcient mutant RT has been shown to bind to
a number of diﬀerent short RNA:DNA hybrid sequences
with low nanomolar aﬃnities that exceed the aﬃnity
observed for wild-type RT (51,52). In addition, single
molecule ﬂuorescence spectroscopy has shown that RT
binds with a 1:1 stoichiometry to PPT substrates
comprising the same sequences used in this study, and
that it overwhelmingly adopts a conﬁguration with the
RNase H domain over the PPT/U3 junction (53).
In the NMR experiment, formation of the complex
between RT and PPTwt, results in general broadening
of the imino proton signals from the PPTwt as would
be expected based on the large size of the complex
(MW>130kDa) when compared to the PPTwt substrate
(MW   14kDa). Nonetheless, more signiﬁcant broad-
ening is observed for a selective subset of imino proton
resonances that is consistent with direct contacts between
RT and the 50 (rA)4:(dT)4 tract and the PPT-U3 junction.
Uniformly subtle downﬁeld shifts are also observed for
imino proton resonances assigned to the G-tract 50 of the
PPT-U3 junction, which further indicates RT contacts at
this end of the PPT. While the broadness of the imino
spectrum of the RT PPT complex only allows a low-
resolution analysis at this time, the qualitative observation
that the addition of RT selectively perturbs a subset of
imino resonances that is similar to those aﬀected by
binding of neomycin B suggests that common regions of
the PPT may be contacted in both cases. The fact that the
perturbations to the spectra are not identical in the two
experiments is not surprising considering that the chemical
nature of the neomycin B versus RT contacts with the PPT
are likely very diﬀerent. Nonetheless, the RT PPT data
support the general premise that neomycin B highlights
uniquely structured sites along the PPT that appear to
coincide with contact points for protein binding. We
would also note that the RT PPT spectra we have
obtained are the only ones to date analyzing this HIV
nucleoprotein complex.
Thermodynamics of PPT wt—neomycin Bbinding
Since neomycin B showed speciﬁc binding to the same
regions of the wild-type PPT RNA:DNA hybrid, we next
investigated the thermodynamic characteristics of these
interactions. ITC allows determination of association
constants and other thermodynamic parameters of bind-
ing equilibria involving both protein (54) and nucleic acid
(55) substrates. For this reason, titration of PPTwt with
neomycin B was followed by ITC in solutions of diﬀerent
salt content (i.e. 80mM and 240mM NaCl) to modulate
the strength of electrostatic interactions and discriminate
against possible non-speciﬁc binding.
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Figure 5. Tandem mass spectrum of the non-covalent 1:2 PPTwt:neomycin B complex (observed mass 13762.43 Da, calculated from sequence
13762.57 Da, see Materials and methods section). For clarity, only some of the characteristic ion series are labeled on the spectrum, which contain
either the 50-o r3 0-end (e.g. ax B and yx, with x indicating the numeration from the respective end;  B indicates the loss of nucleobase at the site of
cleavage). The asterisk symbol identiﬁes products containing non-covalently bound neomycin B. All product ions observed for the DNA and RNA
strands that constitute the substrate are reported on the respective sequences to highlight nucleotides prevented from undergoing fragmentation in the
presence of bound ligand (32). The lines mark the phosphodiester bond cleaved by the gas-phase dissociation processes, pointing toward the
respective end included in each fragment; asterisk indicates products containing noncovalently bound neomycin B. In this case, two distinct gaps are
evident in the ion series observed for the DNA and RNA components of the construct, thus revealing the presence of two separate binding sites.
2806 Nucleic Acids Research, 2008, Vol. 36, No. 8The ITC proﬁles at both ionic strengths are shown in
Figure 7a and c. Each peak corresponds to a single 5.0ml
injection of ligand (see Materials and methods section),
which was subsequently integrated to yield the associated
heats (Figure 7b and d). Control experiments were also
performed by adding identical amounts of neomycin B to
the buﬀer solution devoid of substrate to determine the
respective heats of dilution. At low ionic strength, the plot
of heat exchanged versus ligand/substrate ratio was
biphasic, indicating that the binding events in solution
could be best described by two distinct sets of equilibria
(Figure 7b). At higher ionic strength, however, a mono-
phasic proﬁle was obtained, which could be best described
by a single set of binding equilibria (Figure 7d). The two
plots were further processed to derive the corresponding
values of association constant (Ka), binding enthalpy
(Hobs) and stoichiometry (N), which are summarized
in Table 2.
The ITC results support a primary neomycin B
binding site on the PPT with a relatively high aﬃnity
and a 1:1 stoichiometry at both high and low ionic
strengths. A second set of equivalent binding sites, with
a stoichiometry of 2.34, was only detected at low ionic
strength. This is indicative of less speciﬁc interactions
and correlates with the intermediate exchange processes
observed by
1H NMR upon adding a second equivalent of
neomycin B. The aﬃnities observed for speciﬁc neomycin
B binding to the PPTwt hybrid are consistent with
those observed for speciﬁc sites characterized in other
nucleic acid complexes (56). In addition, the sizeable
contribution of electrostatic interactions to the stability
of aminoglycoside binding can be readily appreciated
from the reduction of two orders of magnitude (i.e.
from 1.45 10
7M
 1 to 1.07 10
5M
 1) for the Ka of the
primary site after raising ionic strength. In this
direction, docking experiments involving aminoglycoside
antibiotics and RNA stem-loops of the HIV-1 packaging
signal have clearly demonstrated the preferential binding
of these positively charged ligands to regions that present
a high density of negative charges on the substrate
surface (32).
Conclusions
The application of archetypical nucleic acid ligands as
non-covalent probes provides valuable information not
only on motifs capable of sustaining stable binding, but
also on the nature of the speciﬁc interactions (31,32). The
binding modes exhibited by the intercalating agents
ethidium bromide and mitoxantrone are consistent with
decreasing stacking stabilization in the PPT series, from
duplex DNA to RNA:DNA hybrid to RNA duplex.
The fact that the two hybrids displayed comparable
aﬃnities indicates that stacking interactions do not
determine recognition speciﬁcity on the wild-type PPT.
Similar conclusions can be drawn from the binding
modes provided by the groove-binder distamycin A,
which tracked very closely the typical narrowing of the
minor groove in moving from a canonic B-type to
an A-type double helix. This probe, however, revealed
subtle diﬀerences in aﬃnity between hybrid constructs,
possibly reﬂecting eﬀects of sequence and strand sense on
groove geometry.
Considering that aminoglycoside ligands bind nucleic
acid duplexes with an RNA:RNA>RNA:DNA>>DNA:
DNA scale of binding aﬃnities (56,57), the preferential
interaction of neomycin B with the wild-type RNA:DNA
hybrid provides important evidence regarding the
determinants of PPT recognition. The fact that this
non-covalent probe manifested greater aﬃnity for the
wild-type hybrid than for its duplex RNA analogue
diminishes the signiﬁcance of generic canonical A-form
helical structure in determining binding speciﬁcity (56), and
highlights the importance of helix plasticity in adapting
favorable electronegative surfaces for ligand interactions
(46). The structural context of such surfaces is determinant
and is expected to assume a clearly unique form in the wild-
type substrate, as shown by comparison with the swapped
construct, which displayed moderate aﬃnity similar to non-
PPT hybrids (56). In the case of the weaker 50 (rA)4:(dT)4
site, the observed interaction is consistent with the ability of
poly(rA)/poly(dT) triplexes to support speciﬁc aminoglyco-
side binding (58). However, there are no reported
Figure 6. One-dimensional water ﬂip-back watergate
1H NMR spectra
of the imino region of the PPTwt duplex after titration with neomycin B
at 108C, or E478Q RT at 308C, in 80mM NaCl and 10mM NaH2PO4/
Na2HPO4 at pH 7.0. (a) For the neomycin titration, the concentration
of the PPTwt duplex was  200mM. 1D
1H NMR spectra are shown in
the absence (upper trace) and presence of 1.0 equivalents (middle trace)
and 2.0 equivalents (lower trace) of neomycin B. The imino resonances
for G(+2), T(+1), and g( 1) where chemical shift changes can be
tracked are highlighted in bold. Dotted lines and arrows indicate the
shift in position of the resonances. (b) For the E478Q RT titration, the
concentration of PPTwt was  40mM. 1D
1H NMR spectra are shown
for PPTwt in the absence (upper trace) and presence of 1.0 equivalent
(lower trace) of E478Q RT. Imino protons were assigned using 2D
NOESY experiments; assignments are listed above each peak.
Nucleic Acids Research, 2008, Vol. 36, No. 8 2807precedents for aminoglycoside interactions with
RNA:DNA hybrid structures in the absence of bulges,
mispaired bases, or other obvious structural anomalies, as
in the PPT-U3 junction.
With its ﬂexible backbone and polycationic character,
neomycin B mimics the binding properties of basic
peptides (46) and thus can indirectly provide insight into
the mechanism of RT binding. The only available
structure of an RT PPT complex has the hybrid substrate
placed in a  60A ˚ cleft of the enzyme with numerous
intermolecular contacts distributed along its length (PDB
ID: 1HYS) (17). Considering that the same cleft is
employed to bind any non-PPT RNA:DNA duplex
formed during reverse transcription, it is not clear how
this diﬀuse set of molecular contacts may translate into
stringent substrate recognition. Unfortunately, in the
high-resolution structure, the RNase H domain of RT
was not positioned over the PPT-U3 junction, precluding
identiﬁcation of structural elements that might promote
speciﬁc recognition. The non-covalent probe neomycin B
clearly points toward the U3 junction and 50 (rA)4:(dT)4
tract as favorable sites for preferential protein interactions
driving recognition. The fact that the spacing between
these PPT sites coincides closely with the distance between
the RNase H active site and thumb subdomain of RT
supports a requirement for proper matching between
cognate structures as an additional element of recognition
speciﬁcity. The results presented here provide strong
experimental support to the proposed map of RT-PPT
contacts shown in Figure 1.
Finally, the absence of probe binding in the region
between the PPT-U3 junction and 50 (rA)4:(dT)4 tract
indicates that the corresponding cleft residues between
Figure 7. ITC titration of PPTwt with neomycin B in 10mM NaH2PO4/Na2HPO4 at pH 7.0 and 308C. (a) ITC proﬁle obtained at 80mM NaCl;
(b) integration of panel (a) and curve-ﬁtting to a model including two sets of equivalents sites; (c) ITC proﬁle obtained at 240mM NaCl;
(d) integration of panel (c) and curve-ﬁtting to a model including one set of equivalent sites. The integrations in panels (b) and (d) were corrected for
the heats of dilution from the titration of neomycin B into the respective buﬀer alone.
Table 2. Thermodynamic characteristics obtained by ITC of the
wild-type PPT construct with neomycin B at 308C
Salt conditions 80mM NaCl 240mM NaCl
T (8C) 30.0 30.0
N1 1.09 0.0075 1.25 0.025
K1 (10
5/M) 145 10 1.07 0.050
H1 (kcal/mol)  9.70 0.027  1.11 0.029
TS1 (kcal/mol)  2.94  4.07
N2 2.34 0.0063 NA
K2 (10
5/M) 2.76 0.037 NA
H2 (kcal/mol)  7.47 0.036 NA
TS2 (kcal/mol) 0.073 NA
NA: not applicable.
2808 Nucleic Acids Research, 2008, Vol. 36, No. 8the RNase H domain and thumb subdomain play no
signiﬁcant role in speciﬁc substrate recognition. This
observation implies that these domains may function as
discrete binding units in the context of a putative
bifunctional ligand, such as RT. The widely diﬀerent
binding modes exhibited by the substrate sites with the
monofunctional probe neomycin B suggest a scenario in
which the initial binding of either of these domains to
the high-aﬃnity site on the PPT-U3 junction could be
followed by subsequent binding of the remaining domain
to the low-aﬃnity site on the 50 (rA)4:(dT)4 tract. The fact
that the second binding event is a unimolecular rather
than a bimolecular process would compensate for the
weaker and less speciﬁc nature of the interactions
sustained by the 50 (rA)4:(dT)4 tract. The possibility that
the interplay between these binding events may mediate
the orientation of RT onto the PPT substrate at diﬀerent
stages of the RT process will be the object of future
investigations.
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